Recently, Hefei En Biotech Co., Ltd. has officially commenced operations, with BAOSHENG serving as its legal representative and a registered capital of 10 million yuan. The company's core focus encompasses the manufacturing, technological research and development, as well as the sales of bio-based materials. It is dedicated to advancing the research and development of bio-based material polymerization technology. The equity structure reveals that Hefei En Biotech is a joint venture, invested by Inner Mongolia Yili Industrial Group's Shenzhen Jianling Innovation Seed Private Equity Investment Fund Partnership, among other investors.